Anaplastic lymphoma kinase (ALK) is a gene whose rearrangement results in a genetic alteration in the ALK gene leading to abnormal protein production and cellular signaling, and which acts as a driver mutation in 5% of NSCLC [78]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.